Hostname: page-component-8448b6f56d-t5pn6 Total loading time: 0 Render date: 2024-04-23T19:38:26.663Z Has data issue: false hasContentIssue false
  • English
  • Français

Effects of two different local anaesthetic methods vs no anaesthesia on pain scores for intratympanic injections

Published online by Cambridge University Press:  08 November 2016

N Ata ,
O Erdur ,
M H Görgülü  and
E Yilmaz
N Ata
Affiliation:
Department of Otorhinolaryngology, Gaziantep 25 Aralık State Hospital, Turkey
O Erdur*
Affiliation:
Department of Otorhinolaryngology, Selçuk University Faculty of Medicine, Konya, Turkey
M H Görgülü
Affiliation:
Department of Otorhinolaryngology, Bartın State Hospital, Turkey
E Yilmaz
Affiliation:
Department of Otorhinolaryngology, Konya Training and Research Hospital, Turkey
*
Address for correspondence: Dr O Erdur, Selcuk University Alaeddin Keykubad Campus, 42075 Konya, Turkey Fax: +90 332 241 60 65 E-mail: dromerdur@yahoo.com
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

This study compared the pain associated with the intratympanic injection combined with various local anaesthetics vs without anaesthesia.

Methods:

The study included 40 patients (aged 18–78 years) who received intratympanic steroid injections for sudden idiopathic hearing loss or tinnitus. Each patient underwent all three injection methods at one-week intervals. Patients received one of two local anaesthetics (lidocaine injection or lidocaine spray) or no anaesthesia before intratympanic injection, and used a visual analogue scale to indicate the pain level after 5 and 45 minutes.

Results:

Five minutes after injection, patients who did not receive anaesthesia and those who received lidocaine spray reported lower pain scores than those who received a lidocaine injection (p < 0.05). There was no difference in pain scores for all three methods at 45 minutes after intratympanic injection.

Conclusion:

Neither of the local anaesthetics was found to be superior to having no anaesthesia.

Keywords

InjectionPainAnesthesiaPain MeasurementVisual Analog Scale
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 130 , Issue 12 , December 2016 , pp. 1153 - 1157
Copyright
Copyright © JLO (1984) Limited 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Crawley, BK, Close, A, Canto, C, Harris, JP. Susac's syndrome: intratympanic therapy for hearing loss and a review of the literature. Laryngoscope 2009;119:141–4CrossRefGoogle Scholar
2 Erdur, O, Kayhan, FT, Cirik, AA. Effectiveness of intratympanic dexamethasone for refractory sudden sensorineural hearing loss. Eur Arch Otorhinolaryngol 2014;271:1431–6Google Scholar
3 Fu, Y, Zhao, H, Zhang, T, Chi, F. Intratympanic dexamethasone as initial therapy for idiopathic sudden sensorineural hearing loss: clinical evaluation and laboratory investigation. Auris Nasus Larynx 2011;38:165–71CrossRefGoogle ScholarPubMed
4 Alles, MJ, der Gaag, MA, Stokroos, RJ. Intratympanic steroid therapy for inner ear diseases, a review of the literature. Eur Arch Otorhinolaryngol 2006;263:791–7Google Scholar
5 Choi, SJ, Lee, JB, Lim, HJ, In, SM, Kim, JY, Bae, KH et al. Intratympanic dexamethasone injection for refractory tinnitus: prospective placebo-controlled study. Laryngoscope 2013;123:2817–22Google Scholar
6 Barrs, DM. Intratympanic injections of dexamethasone for long-term control of vertigo. Laryngoscope 2004;114:1910–14Google Scholar
7 Belhassen, S, Saliba, I. Pain assessment of the intratympanic injections: a prospective comparative study. Eur Arch Otorhinolaryngol 2012;269:2467–73Google Scholar
8 Plaza, G, Herraiz, C. Intratympanic steroids for treatment of sudden hearing loss after failure of intravenous therapy. Otolaryngol Head Neck Surg 2007;137:74–8Google Scholar
9 Tezer, MS, Baran, Y, Erdur, O, Ata, N, Arslanhan, M. Comparison of systemic, intratympanic and combination therapy of the steroids for the treatment of sudden sensorineural hearing loss. J Med Sci 2013;33:353–9Google Scholar
10 Paksoy, M, Altin, G, Eken, M, Hardal, U. Effectiveness of intratympanic dexamethasone in otitis media with effusion resistant to conventional therapy. Indian J Otolaryngol Head Neck Surg 2013;65:461–7Google Scholar
11 Parnes, LS, Sun, AH, Freeman, DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1–17 Google Scholar
12 Choung, YH, Park, K, Shin, YR, Cho, MJ. Intratympanic dexamethasone injection for refractory sudden sensorineural hearing loss. Laryngoscope 2006;116:747–52Google Scholar
13 Dispenza, F, De Stefano, A, Costantino, C, Marchese, D, Riggio, F. Sudden sensorineural hearing loss: results of intratympanic steroids as salvage treatment. Am J Otolaryngol 2013;34:296–300 CrossRefGoogle ScholarPubMed
14 Garduño-Anaya, MA, Couthino De Toledo, H, Hinojosa-González, R, Pane-Pianese, C, Ríos-Castañeda, LC. Dexamethasone inner ear perfusion by-blind, randomized trial. Otolaryngol Head Neck Surg 133:285–94Google Scholar
15 Topak, M, Sahin-Yilmaz, A, Ozdoganoglu, T, Yilmaz, HB, Ozbay, M, Kulekci, M. Intratympanic methylprednisolone injections for subjective tinnitus. J Laryngol Otol 2009;123:1221–5CrossRefGoogle ScholarPubMed
16 Chung, JH, Park, CW, Lee, SH, Kim, BS, Cho, SH, Kim, HY et al. Intratympanic steroid injection for Bell's palsy: preliminary randomized controlled study. Otol Neurotol 2014;35:1673–8Google Scholar
17 Yang, F, Zhao, Y, An, P, Zheng, Y, Yu, R, Gu, D et al. Longitudinal results of intratympanic injection of budesonide for otitis media with effusion in children over 12 years and adults. Otol Neurotol 2014;35:629–34CrossRefGoogle ScholarPubMed
18 Parnes, LS, Sun, AH, Freeman, DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999;109:1–17 Google Scholar
19 Lavigne, P, Lavigne, F, Saliba, I. Intratympanic corticosteroids injections: a systematic review of literature. Eur Arch Otorhinolaryngol 2015;273:2271–8CrossRefGoogle ScholarPubMed
20 Han, CS, Park, JR, Boo, SH, Jo, JM, Park, KW, Lee, WY et al. Clinical efficacy of initial intratympanic steroid treatment on sudden sensorineural hearing loss with diabetes. Otolaryngol Head Neck Surg 2009;141:572–8CrossRefGoogle ScholarPubMed
21 Ferri, E, Frisina, A, Fasson, AC, Armato, E, Spinato, G, Amadori, M. Intratympanic steroid treatment for idiopathic sudden sensorineural hearing loss after failure of intravenous therapy. ISRN Otolaryngol 2012;2012:647271 Google Scholar
22 Gouveris, H, Selivanova, O, Mann, W. Intratympanic dexamethasone with hyaluronic acid in the treatment of idiopathic sudden sensorineural hearing loss after failure of intravenous steroid and vasoactive therapy. Eur Arch Otorhinolaryngol 2005;262:131–4CrossRefGoogle ScholarPubMed
23 Kaweski, S. Topical anesthetic creams. Plast Reconstr Surg 2008;121:2161–5Google Scholar
24 Martellucci, S, Pagliuca, G, de Vincentiis, M, Greco, A, Fusconi, M, De Virgilio, A et al. EMLA(®) cream as local anesthetic for radiofrequency turbinate tissue reduction. Eur Arch Otorhinolaryngol 2014;271:2717–22Google Scholar
25 Tremont-Lukats, IW, Challapalli, V, McNicol, ED, Lau, J, Carr, DB. Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 2005;101:1738–49Google Scholar
26 Bierrina, P, Arnendt-Nielson, L. Depth and duration of skin analgesia to needle insertion after topical application of EMLA cream. Br J Anaesth 1990;64:173–7Google Scholar
27 Filipo, R, Covelli, E, Balsamo, G, Attanasio, G. Intratympanic prednisolone therapy for sudden sensorineural hearing loss: a new protocol. Acta Otolaryngol 2010;130:1209–13Google Scholar
28 Filipo, R, Attanasio, G, Russo, FY, Viccaro, M, Mancini, P, Covelli, E. Intratympanic steroid therapy in moderate sudden hearing loss: a randomized, triple-blind, placebo-controlled trial. Laryngoscope 2013;123:774–8Google Scholar